Clinical trial
Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related…
NCT00460967 · OccuLogix, Industry · Suspended
Key facts
| NCT number | NCT00460967 |
|---|---|
| Title | Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis |
| Official title | Safety and Effectiveness, in a Multi-Center, Randomized, Sham Controlled Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD)Using Rheopheresis |
| Acronym | RHEO-AMD |
| Lead sponsor | OccuLogix, Industry |
| Status | Suspended |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Age-Related Maculopathy |
| Intervention type | Device |
| Interventions | Rheopheresis |
| Enrollment | 325 |
| Start date | Jan 1, 2007 |
| Completion | Dec 1, 2009 |
| First posted | Apr 17, 2007 |
| Last update posted | Nov 7, 2007 |
| Countries | Canada, Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: